These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19048593)

  • 1. [Treatment of post-transplant glomerulonephritis].
    Sandrini S; Valerio F
    G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art].
    Cravedi P
    G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
    Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine treatment of glomerular diseases.
    Klein M; Radhakrishnan J; Appel G
    Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant recurrence of primary glomerulonephritis.
    Ponticelli C; Glassock RJ
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2363-72. PubMed ID: 21030574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous immunoglobulins in the treatment of glomerulopathies].
    Floccari F; Palla R; Polito P; Campo S; Aloisi C; Buemi M
    G Ital Nefrol; 2007; 24(4):311-9. PubMed ID: 17659502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
    Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A primer on recurrent and de novo glomerulonephritis in renal allografts.
    Ivanyi B
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis.
    Requião-Moura LR; Moscoso-Solorzano GT; Franco MF; Ozaki KS; Pacheco-Silva A; Kirsztajn GM; Câmara NO
    Clin Transplant; 2007; 21(3):363-70. PubMed ID: 17488386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis.
    Damodar A; Mustafa R; Bhatnagar J; Panesar M; Gundroo A; Zachariah M; Blessios G; Tornatore K; Weber-Shrikant E; Venuto R
    Clin Transplant; 2011; 25(3):375-9. PubMed ID: 20384712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
    Murakami C; Manoharan P; Carter-Monroe N; Geetha D
    Transpl Int; 2013 Dec; 26(12):1225-31. PubMed ID: 24118474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
    Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
    Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.